Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1/5/8 signaling pathway.

[1]  T. Yamaoka,et al.  Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase , 2014, Heart and Vessels.

[2]  A. Sarkaki,et al.  Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats. , 2014, European journal of pharmacology.

[3]  H. Maurya,et al.  Prophylactic Antioxidant Potential of Gallic Acid in Murine Model of Sepsis , 2014, International journal of inflammation.

[4]  S. Nabavi,et al.  Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat! , 2014, Current pharmaceutical biotechnology.

[5]  V. Rosen,et al.  HtrA1 is upregulated during RANKL‐induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2‐induced Smad1/5/8, ERK and p38 phosphorylation , 2014, FEBS letters.

[6]  H. Beppu,et al.  Bone Morphogenetic Proteins Signal Via SMAD and Mitogen-activated Protein (MAP) Kinase Pathways at Distinct Times during Osteoclastogenesis* , 2013, The Journal of Biological Chemistry.

[7]  B. Zhao,et al.  Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells , 2013, Oncology letters.

[8]  K. Asokkumar,et al.  Antiulcerogenic Effect of Gallic Acid in Rats and its Effect on Oxidant and Antioxidant Parameters in Stomach Tissue , 2013, Indian journal of pharmaceutical sciences.

[9]  Sirshendu Chatterjee,et al.  Gallic Acid Enriched Fraction of Phyllanthus emblica Potentiates Indomethacin-Induced Gastric Ulcer Healing via e-NOS-Dependent Pathway , 2012, Evidence-based complementary and alternative medicine : eCAM.

[10]  P. ten Dijke,et al.  BMP signaling in vascular diseases , 2012, FEBS letters.

[11]  C. Peng,et al.  Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease. , 2012, Clinical nutrition.

[12]  Feroz Khan,et al.  Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity , 2012, Journal of Molecular Modeling.

[13]  E. Aikawa,et al.  Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[14]  P. Akarasereenont,et al.  UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid. , 2012, Journal of photochemistry and photobiology. B, Biology.

[15]  R. Goyal,et al.  Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats , 2011, Pharmacognosy research.

[16]  Hiroki Matsui,et al.  Notch Signaling Pathway Enhances Bone Morphogenetic Protein 2 (BMP2) Responsiveness of Msx2 Gene to Induce Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells* , 2011, The Journal of Biological Chemistry.

[17]  HiroakiMatsubara,et al.  Paracrine Osteogenic Signals via Bone Morphogenetic Protein-2 Accelerate the Atherosclerotic Intimal Calcification In Vivo , 2010 .

[18]  M. Festing,et al.  Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1 , 2010, Thrombosis and Haemostasis.

[19]  Kyung-Chul Choi,et al.  Gallic Acid Suppresses Lipopolysaccharide-Induced Nuclear Factor-κB Signaling by Preventing RelA Acetylation in A549 Lung Cancer Cells , 2009, Molecular Cancer Research.

[20]  Xianwu Li,et al.  BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. , 2008, Atherosclerosis.

[21]  Yin Tintut,et al.  Vascular calcification: pathobiology of a multifaceted disease. , 2008, Circulation.

[22]  Xingguo Chen,et al.  Studies on the interaction of caffeic acid with human serum albumin in membrane mimetic environments. , 2008, Journal of photochemistry and photobiology. B, Biology.

[23]  Chin-Lin Hsu,et al.  Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. , 2007, The British journal of nutrition.

[24]  Y. Shimono,et al.  Enhancer of Polycomb1, a Novel Homeodomain Only Protein-binding Partner, Induces Skeletal Muscle Differentiation* , 2007, Journal of Biological Chemistry.

[25]  C. Shanahan,et al.  VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: The Vascular Biology of Calcification , 2007 .

[26]  K. Hruska,et al.  Bone Morphogenetic Proteins in Vascular Calcification , 2005, Circulation research.

[27]  N. Chen,et al.  Inflammation and Vascular Calcification , 2004, Blood Purification.

[28]  G. Beck,et al.  Osteopontin Regulation by Inorganic Phosphate Is ERK1/2-, Protein Kinase C-, and Proteasome-dependent* , 2003, Journal of Biological Chemistry.

[29]  I. Stupans,et al.  Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. , 2003, Current drug metabolism.

[30]  P. Weissberg,et al.  Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Xingguo Chen,et al.  Studies on the interaction of gallic acid with human serum albumin in membrane mimetic environments. , 2008, Talanta.

[32]  折田 裕一.  Role of osteoprotegerin in arterial calcification development of new animal model , 2007 .

[33]  M. Crow,et al.  Vascular smooth muscle cell cultures. , 1997, Methods in cell biology.